Currently, the main treatments for DN are glycemic, lipid and blood pressure control, plus renin-angiotensin-aldosterone system (RAAS) blockade, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) [3]. The gene discussed is ACE; the disease is liver dysplastic nodule.